Biopharmaceutical Characterization of Ciprofloxacin HCl-Ferrous Sulfate Interaction
Authorized Users Only
Paluch, Krzysztof J.
Corrigan, Owen I.
Article (Published version)
MetadataShow full item record
The ciprofloxacin-iron interaction, resulting in a lower bioavailability, is well documented in vivo; however, a mechanistic explanation supported by experimental data of this interaction is missing. In the present study, ciprofloxacin hydrochloride (HCl) and ferrous sulfate interaction was simulated in vitro by performing solubility and dissolution studies in the reactive media containing ferrous sulfate. Characterization of the precipitate formed indicated its probable chemical structure as Fe(SO(4)(2-))(2)(Cl(-))(2)(ciprofloxacin)(2) x (H(2)O)(n), where n is up to 12 molecules of water. The solubility of this complex in water was estimated to be approximately 2mg/mL, being about 20-fold lower than the solubility of ciprofloxacin HCl. The solubility of the complex was used as input parameter for an in silico modeling by GastroPlus (TM) and the resulting predicted plasma time curves were in good agreement with the in vivo data. These results strongly indicate that ciprofloxacin-iron i...nteraction in vivo is caused by the formation of a low soluble complex. This interaction was also simulated by in vitro dissolution, in which a mini scale apparatus provided more biorelevant results than the standard dissolution apparatus, probably because the drug concentrations in the mini apparatus were higher and, thus, closer to the conditions encountered in vivo.
Keywords:bioavailability / Biopharmaceutics Classification System (BCS) / ciprofloxacin HCl / dissolution / drug interaction / in silico modeling / ferrous sulfate / oral absorption / solubility
Source:Journal of Pharmaceutical Sciences, 2011, 100, 12, 5174-5184
- Wiley-Blackwell, Malden
- Advanced technologies for controlled release from solid drug delivery systems (RS-34007)
- Solid State Pharmaceutical Cluster